Bristol-Myers Squibb Company (BMY) Cash Flow Statement
Bristol-Myers Squibb Company (BMY) generated $12.8B of operating cash flow over the twelve months to 2026-06-30, spent $1.3B on capital expenditure and had free cash flow of $11.4B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BMYBristol-Myers Squibb CompanyFollow BMY — free
—
Price chart with a free account
- Market cap
- 125.6B
- P/E TTM
- 13.5
- Dividend yield
- 4.1%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.07 | 4.49 | 4.84 | 6.94 | 3.55 | 3.15 | 2.11 | 3.06 | 5.28 | 7.07 | 8.21 | 14.05 | 16.21 | 13.07 | 13.86 | 15.19 | 14.16 | 12.78 | |
| Capital expenditure | 0.73 | 0.42 | 0.37 | 0.55 | 0.54 | 0.53 | 0.82 | 1.22 | 1.06 | 0.95 | 0.84 | 0.75 | 0.97 | 1.12 | 1.21 | 1.25 | 1.31 | -1.34 | |
| Free cash flow | 3.34 | 4.07 | 4.47 | 6.39 | 3.01 | 2.62 | 1.29 | 1.84 | 4.22 | 6.12 | 7.37 | 13.30 | 15.23 | 11.95 | 12.65 | 13.94 | 12.85 | 11.44 | |
| Dividends paid | 2.48 | 2.20 | 2.25 | 2.29 | 2.31 | 2.40 | 2.48 | 2.55 | 2.58 | 2.61 | 2.68 | 4.08 | 4.40 | 4.63 | 4.74 | 4.86 | 5.05 | — | |
| Share repurchases | — | 0.58 | 1.22 | 2.40 | 0.43 | — | — | 0.23 | 2.47 | 0.32 | 7.30 | 1.55 | 6.29 | 8.00 | 5.16 | 0.00 | 0.00 | — | |
| Stock-based compensation | 0.18 | 0.19 | 0.16 | 0.15 | 0.19 | 0.21 | 0.24 | 0.21 | 0.20 | 0.22 | 0.44 | 0.78 | 0.58 | 0.46 | 0.52 | 0.51 | 0.55 | — |
USD billions · SEC XBRL
Bristol-Myers Squibb Company — questions
- What is Bristol-Myers Squibb Company's operating cash flow?
- $12.8B over the twelve months to 2026-06-30.
- How much does Bristol-Myers Squibb Company spend on capital expenditure?
- $1.3B over the twelve months to 2026-06-30.
- What is Bristol-Myers Squibb Company's free cash flow?
- $11.4B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Bristol-Myers Squibb Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.